Harvard University
Cambridge, United States
Team details appear once the team leader joins.
Is this your team? Claim it
High blood pressure
FollowWhat is new in High blood pressure research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- [18F]FAPI-74Phase 3 · NCT07613099
- Acetazolamide-based medical therapyPhase 3 · NCT05707442
- Acetylsalicylic acidPhase 3 · NCT05460416
- AD-227APhase 3 · NCT06441630
- AD-227BPhase 3 · NCT06441630
- AD-227CPhase 3 · NCT06441630
- Allopurinol 200 mgPhase 3 · NCT05943821
- AmbrisentanPhase 3 · NCT07245680
- AmlodipinePhase 3 · NCT06150560 · NCT05312892 · NCT07618806
- Anti-hypertensive medication titrated to a BP goal of <140/90 mmHgPhase 3 · NCT07746271
- Antihypertensive algorithmPhase 3 · NCT05732727
- ApixabanPhase 3 · NCT04007289
- Aprocitentan tablets(SYH9108)Phase 3 · NCT07635914
- Aspirin 150 mgPhase 3 · NCT04356326
- baxdrostat 2mgPhase 3 · NCT07686120
- Baxdrostat/dapagliflozinPhase 3 · NCT06268873 · NCT06742723 · NCT07222917
- Bimatoprost Implant SystemPhase 3 · NCT07218796 · NCT07218783
- bimatoprost ophthalmic solution 0.01% (Lumigan®)Phase 3 · NCT07661329
- Bimatoprost ophthalmic solution 0.01% YSBPPhase 3 · NCT07661329
- BR1019APhase 3 · NCT06220773
- BR1019A-1Phase 3 · NCT06220773
- BR1019BPhase 3 · NCT06220773
- BR1019B-1Phase 3 · NCT06220773
- BR1019CPhase 3 · NCT06220773
- BR1019C-1Phase 3 · NCT06220773
- Bramicar HCTPhase 3 · NCT07030101
- Bupropion 150 mgPhase 3 · NCT07806279
- C2402Phase 3 · NCT06643130
- Candesartan/AmlodipinePhase 3 · NCT06646354
- Candesartan/Rosuvastatin/EzetimibePhase 3 · NCT06646354
- Commercial IOLPhase 3 · NCT07218796 · NCT07218783
- Control group 1Phase 3 · NCT07552389
- Control group 2Phase 3 · NCT07552389
- COSOPT®Phase 3 · NCT07617532
- Dapagliflozin in combination with placeboPhase 3 · NCT06268873
- DE-117B Eye DropsPhase 3 · NCT06666855
- Dehydrated alcoholPhase 3 · NCT02910414
- Dehydrated Alcohol Injection, USPPhase 3 · NCT07083765
- Discontinuation of riociguatPhase 3 · NCT07644377
- DoxycyclinePhase 3 · NCT05473520
- Dry Powder InhalerPhase 3 · NCT07816185 · NCT07333183 · NCT06635850
- empagliflozinPhase 3 · NCT06507657 · NCT07064473 · NCT06570473
- EnalaprilPhase 3 · NCT07222852
- EptinezumabPhase 3 · NCT07645833
- Experimental group: Patients will be treated with carvedilol.Phase 3 · NCT06263816
- Exploratory test groupPhase 3 · NCT07552389
- Ezetimibe/Rosuvastatin/Candesartan/AmlodipinePhase 3 · NCT06646354
- FETO, Fetal Endoluminal Tracheal OcclusionPhase 3 · NCT07187206
- Furosemide 20 MilligramsPhase 3 · NCT07008365
- Gen 2 Travoprost Intracameral ImplantPhase 3 · NCT07075718 · NCT07495852
- Gereic Dry Powder InhalerPhase 3 · NCT06274801
- Guideline-directed medical therapy (GDMT) for heart failurePhase 3 · NCT05824923
- HCP1803-3Phase 3 · NCT07660796
- HCP1803-4Phase 3 · NCT07660796
- HRS-7535Phase 3 · NCT07528027
- Huayu Jiedu Formula (FTFY-919) GranulesPhase 3 · NCT07801599
- Huayu Jiedu Formula (FTFY-919) Traditional DecoctionPhase 3 · NCT07801599
- HUC3-637Phase 3 · NCT07335211
- HUC3-637-RPhase 3 · NCT07335211
- IBI362Phase 3 · NCT07469800
- IKT-001Phase 3 · NCT07632898 · NCT07365332
- Intranasal dexmedetomidinePhase 3 · NCT07080229
- Intranasal normal salinePhase 3 · NCT07080229
- JW0104+C2402Phase 3 · NCT06643130
- JW0104+C2403Phase 3 · NCT06643130
- L606Phase 3 · NCT07285655
- L606 inhalation suspensionPhase 3 · NCT04691154
- Labetalol, NifedipinePhase 3 · NCT04298034
- LatanoprostPhase 3 · NCT06666855
- LevamlodipinePhase 3 · NCT06771245
- Levamlodipine placeboPhase 3 · NCT06771245
- LIQ861 Inhaled TreprostinilPhase 3 · NCT03992755
- lorundrostatPhase 3 · NCT05968430
- LosartanPhase 3 · NCT06150560
- Low Energy SLTPhase 3 · NCT04967989
- MacitentanPhase 3 · NCT05179876
- Macitentan 10 mgPhase 3 · NCT04273945
- Macitentan 37.5 mgPhase 3 · NCT04273945
- Macitentan 75 mgPhase 3 · NCT04273945
- Macitentan/Tadalafil FDCPhase 3 · NCT05179876
- Metformin HydrochloridePhase 3 · NCT06452498
- Micardis AnloPhase 3 · NCT07030101
- MosliciguatPhase 3 · NCT07816185 · NCT06635850
- Nifedipine ERPhase 3 · NCT05687344
- Optional interventionPhase 3 · NCT05943821
- Oral LabetalolPhase 3 · NCT05551104
- Oral NifedipinePhase 3 · NCT05551104
- OrforglipronPhase 3 · NCT06948435 · NCT06948422 · NCT06952530
- Peregrine System Kit (Sham Procedure)Phase 3 · NCT02910414
- Peripheral intravenous norepinephrinePhase 3 · NCT06059144
- Perirenal adipose tissue modification by focused power ultrasoundPhase 3 · NCT07232966
- preservative-free parenteral treprostinilPhase 3 · NCT06350032
- Product DNN.31.19.026Phase 3 · NCT07617532
- Pulmonary arterial denervationPhase 3 · NCT05824923
- QR12000 150mgPhase 3 · NCT06716970
- QR12000 150mg placeboPhase 3 · NCT06716970
- QR12000 75mgPhase 3 · NCT06716970
- QR12000 75mg placeboPhase 3 · NCT06716970
- RalinepagPhase 3 · NCT03683186
- Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)Phase 3 · NCT05401357
- Renin angiotensin system blockersPhase 3 · NCT05726916
- RICPhase 3 · NCT07562477
- RiociguatPhase 3 · NCT06922240
- Riociguat (Adempas, BAY63-2521)Phase 3 · NCT02562235
- Riociguat PillPhase 3 · NCT04062565
- RLD2001-1Phase 3 · NCT07660796
- RLD2001-2Phase 3 · NCT07660796
- Routine TreatmentPhase 3 · NCT06922240
- Sacubitril/valsartan 200mgPhase 3 · NCT06716970
- Sacubitril/valsartan 200mg placeboPhase 3 · NCT06716970
- Sacubitril∙Valsartan(dose increasing)Phase 3 · NCT06643819
- Sacubitril∙Valsartan(dose maintenance)Phase 3 · NCT06643819
- SelexipagPhase 3 · NCT05179876 · NCT04175600
- SeralutinibPhase 3 · NCT06274801
- SGLT2Phase 3 · NCT06804161
- SHAPE measurement (Definity ultrasoud contrast agent)Phase 3 · NCT05470205
- SHAPE measurement (Sonazoid ultrasoud contrast agent)Phase 3 · NCT05470205
- Silymarine supplementationPhase 3 · NCT06801886
- SOC: Phosphodiesterase type 5 (PDE-5) inhibitorPhase 3 · NCT04175600
- SOC: Soluble guanylate cyclase stimulatorPhase 3 · NCT04175600
- Soliris®Phase 3 · NCT05726916
- SotaterceptPhase 3 · NCT07266519 · NCT05587712 · NCT07218029 · NCT07646860 · NCT06814145 · NCT07839585 · NCT06925750
- SpyGlass IOLPhase 3 · NCT07218796 · NCT06120842 · NCT07218783
- Standard Energy SLTPhase 3 · NCT04967989
- Stent ImplantationPhase 3 · NCT05707442
- SYH9056Phase 3 · NCT06771245
- SYH9056 placeboPhase 3 · NCT06771245
- TadalafilPhase 3 · NCT07245680 · NCT05937854 · NCT05844462
- TCA108Phase 3 · NCT07030101
- Test - Bimatoprost 0.01% Ophthalmic SolutionPhase 3 · NCT05401357
- Test groupPhase 3 · NCT07552389
- TFC-003Phase 3 · NCT07662759
- TFC-003-R1Phase 3 · NCT07662759
- TFC-003-R2+TFC-003-R3Phase 3 · NCT07662759
- THP-00101Phase 3 · NCT06647745
- THP-00102Phase 3 · NCT06647745
- THP-00103Phase 3 · NCT06647745
- THP-00104Phase 3 · NCT06647745
- THP-00105Phase 3 · NCT06647745
- THP-00106Phase 3 · NCT06647745
- Timolol eye drops 0.5%Phase 3 · NCT07036510 · NCT07075718 · NCT07495852
- Timolol Maleate Ophthalmic Solution, 0.5%Phase 3 · NCT07218796 · NCT06120842 · NCT07218783
- TNX-103Phase 3 · NCT07436689 · NCT05983250 · NCT07288398
- Treprostinil Injectable ProductPhase 3 · NCT04062565
- Treprostinil Palmitil Inhalation PowderPhase 3 · NCT07234032 · NCT07179380 · NCT07481981
- ValsartanPhase 3 · NCT06771245 · NCT06643819
- Valsartan Oral SolutionPhase 3 · NCT06863987
- valsartan placeboPhase 3 · NCT06771245
- VI-0106Phase 3 · NCT07612657
- VicadrostatPhase 3 · NCT07064473
- ZilebesiranPhase 3 · NCT07553442 · NCT07181109
- CarvedilolPhase 2/3 · NCT04499898
- Carvedilol and alverinePhase 2/3 · NCT06696248
- DexmedetomidinePhase 2/3 · NCT06935292
- DextrosePhase 2/3 · NCT07824674
- Endoscopic band ligationPhase 2/3 · NCT04499898
- EplerenonePhase 2/3 · NCT07795762 · NCT07727252
- HRS-1780 tabletPhase 2/3 · NCT07708441
- HRS-1780 tablet placeboPhase 2/3 · NCT07708441
- MelatoninPhase 2/3 · NCT06935292
- OxacomPhase 2/3 · NCT06683040
- Praziquantel 40 mg/kg given three times per yearPhase 2/3 · NCT07754617
- Praziquantel 40 mg/kg per dose given once annuallyPhase 2/3 · NCT07754617
- Sacubitril-Valsartan 49 Mg-51 Mg Oral TabletPhase 2/3 · NCT04971720
- Sildenafil 20mgPhase 2/3 · NCT07824674
- Sodium Bicarbonate (NaHCO3)Phase 2/3 · NCT07231900
- Treprostinil PalmitilPhase 2/3 · NCT05649748
- Valsartan 80 mg Oral TabletPhase 2/3 · NCT04971720
- 129Xe HyperpolarizedPhase 2 · NCT04991454 · NCT06351345 · NCT06104228
- 2-HOBA acetate (2-Hydroxybenzlamine acetate)Phase 2 · NCT07225543
- 2-hydroxybenzylaminePhase 2 · NCT07602166
- 3% NaClPhase 2 · NCT06634069
- 6R-BH4Phase 2 · NCT02947750
- AlemtuzumabPhase 2 · NCT03630211
- ALN-AGT01 RVRPhase 2 · NCT07553442
- Alverine CitratePhase 2 · NCT05508633
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)Phase 2 · NCT05331144
- Angiotensin Receptor Blockers (ARBs)Phase 2 · NCT07447206
- Anti Thymocyte GlobulinPhase 2 · NCT03630211
- Anti-hypertensive drugs except ARNIPhase 2 · NCT07261098
- APL-9796Phase 2 · NCT06846554
- Aprepitant 125 and 80Mg Oral CapsulePhase 2 · NCT06462287
- Arm 1: TB0001 ophthalmic solution 0.9%Phase 2 · NCT07913074
- Arm 2: TB0001 ophthalmic solution 1.2%Phase 2 · NCT07913074
- ARNIPhase 2 · NCT07261098
- Background PAH TherapyPhase 2 · NCT06925750
- Baxdrostat/PlaceboPhase 2 · NCT07222917
- BelzutifanPhase 2 · NCT07895966
- BosentanPhase 2 · NCT04388124
- BR1400-1Phase 2 · NCT07373613
- BR1400-2Phase 2 · NCT07373613
- BR1400-3Phase 2 · NCT07373613
- BR1400-4Phase 2 · NCT07373613
- BR1400-5Phase 2 · NCT07373613
- BR1400-APhase 2 · NCT07373613
- BR1400-BPhase 2 · NCT07373613
- BR1400-CPhase 2 · NCT07373613
- Chlorthalidone 25 mg dailyPhase 2 · NCT07238400
- ClazakizumabPhase 2 · NCT07783802
- ColchicinePhase 2 · NCT04916522
- Colchicine 0.5 MG Oral TabletPhase 2 · NCT07907757
- CS1Phase 2 · NCT07761572
- CyclophosphamidePhase 2 · NCT03630211
- DonafenibPhase 2 · NCT06646198
- Dose 1 of QLS1410Phase 2 · NCT07489612
- Dose 2 of QLS1410Phase 2 · NCT07489612
- Dose 3 of QLS1410Phase 2 · NCT07489612
- DroxidopaPhase 2 · NCT01370512
- Empagliflozin 10 MGPhase 2 · NCT06992440
- Eplerenone 100 mg dailyPhase 2 · NCT07238400
- FIM intervention armPhase 2 · NCT07332741
- FIM Usual Care ArmPhase 2 · NCT07332741
- Folic Acid 5 MGPhase 2 · NCT07648251
- FrespaciguatPhase 2 · NCT05612035
- FurosemidePhase 2 · NCT07648251
- Ga-68-DOTATATEPhase 2 · NCT03206060
- GLP-1 agonistPhase 2 · NCT07737522
- GM-CSFPhase 2 · NCT03630211
- GW906Phase 2 · NCT07835971 · NCT07835984
- HRS-9563 InjectionPhase 2 · NCT07297797
- Hydrophilic Statins or Non-Statin AlternativePhase 2 · NCT07447206
- Hyperpolarized 129 Xenon GasPhase 2 · NCT07821398
- Hyperpolarized 129XePhase 2 · NCT04778046
- Hyperpolarized Xe129Phase 2 · NCT04624490 · NCT06038630
- IBI3016Phase 2 · NCT07352969 · NCT07556796
- iloperidonePhase 2 · NCT07090161
- InclisiranPhase 2 · NCT07610278
- Inclisiran placeboPhase 2 · NCT07610278
- inhaled mosliciguatPhase 2 · NCT07333183
- Intravenous immunoglobulinPhase 2 · NCT03630211
- KMgCitPhase 2 · NCT05145309
- L-NAMEPhase 2 · NCT06424756
- LAM-001Phase 2 · NCT07886554 · NCT05798923
- Latanoprost 0.005% Ophthalmic SolutionPhase 2 · NCT06964191
- lipid injectable emulsion with Fish oilPhase 2 · NCT04031508
- Low-dose Colchicine at 0.5mg dailyPhase 2 · NCT07654231
- Lu-177-DOTATATEPhase 2 · NCT03206060
- MANPPhase 2 · NCT06343298
- Matching placebo controlPhase 2 · NCT07142356
- MesnaPhase 2 · NCT03630211
- MetforminPhase 2 · NCT06687265
- MirivadelgatPhase 2 · NCT06475781
- MitoTempoPhase 2 · NCT06424756
- Nicotinamide ribosidePhase 2 · NCT03821623 · NCT04040959
- NorepinephrinePhase 2 · NCT07614438 · NCT01426529
- NS-0200 (higher sildenafil)Phase 2 · NCT07647003
- NS-0200 (low sildenafil)Phase 2 · NCT07647003
- NS-863 High DosePhase 2 · NCT07441278 · NCT07441200
- NS-863 Low DosePhase 2 · NCT07441278 · NCT07441200
- NS-863 PlaceboPhase 2 · NCT07441200
- Oral IfetrobanPhase 2 · NCT02682511
- Oral PlaceboPhase 2 · NCT02682511
- PA5108 Ocular Implant low dosePhase 2 · NCT06964191
- PA5108 Ocular Implant, high dosePhase 2 · NCT06964191
- phase 2A ChlorthalidonePhase 2 · NCT07645300
- phase 2A Chlorthalidone + SpironolactonePhase 2 · NCT07645300
- phase 2A SpironolactonePhase 2 · NCT07645300
- phase 2B Chlorthalidone LD + Spironolactone LDPhase 2 · NCT07645300
- Pioglitazone 30mgPhase 2 · NCT06336798
- Potassium ChloridePhase 2 · NCT07238400
- Potassium PlaceboPhase 2 · NCT07238400
- PyridostigminePhase 2 · NCT01370512
- QCZ484Phase 2 · NCT06857955 · NCT07543120 · NCT07610278
- QCZ484 placeboPhase 2 · NCT07610278
- RanolazinePhase 2 · NCT06570473
- RavulizumabPhase 2 · NCT06333652
- REGN13335Phase 2 · NCT07318597
- relacorilantPhase 2 · NCT03604198
- RituximabPhase 2 · NCT03630211
- ROC-101Phase 2 · NCT07175038
- RTN-001Phase 2 · NCT07142356
- SAL0140Phase 2 · NCT07654140 · NCT07051603
- selexipag (Uptravi)Phase 2 · NCT03492177
- SGLT-2 inhibitorsPhase 2 · NCT07482020
- Sildenafil Oral SuspensionPhase 2 · NCT05201144
- SNP - Sodium NitroprussidePhase 2 · NCT06424756
- sodium chloride injectionPhase 2 · NCT07297797
- Sodium LactatePhase 2 · NCT06634069
- Sotatercept 0.3 mg/kg escalating to 0.7 mg/kgPhase 2 · NCT07266519
- SPC 1001 Mid2Phase 2 · NCT06826872
- SPC 2002Phase 2 · NCT06826872
- SPC 2003Phase 2 · NCT06826872
- SPC 2004Phase 2 · NCT06826872
- SPC1001 LowPhase 2 · NCT07064525
- SPC5002Phase 2 · NCT07064525
- SPC5003Phase 2 · NCT07064525
- SPC5004Phase 2 · NCT07064525
- SpironolactonePhase 2 · NCT01712620
- spironolactone 25 mg orally once dailyPhase 2 · NCT07041281
- SYH2072 TabletsPhase 2 · NCT07911735
- TACE Combined With Tislelizumab, Lenvatinib, and CarvedilolPhase 2 · NCT07350070
- TB0001 ophthalmic solution 1.5%Phase 2 · NCT07913074
- TempolPhase 2 · NCT06424756
- ThiotepaPhase 2 · NCT03630211
- Timolol 0.05% eye dropsPhase 2 · NCT07913074
- Tiprelestat (10 mg)Phase 2 · NCT07601295
- Tiprelestat (5 mg)Phase 2 · NCT07601295
- TonlamarsenPhase 2 · NCT07511361
- Total Body IrradiationPhase 2 · NCT03630211
- Transjugular intrahepatic portosystemic shunt (TIPS)Phase 2 · NCT06646198
- TreprostinilPhase 2 · NCT07177703 · NCT07837830
- TX000045Phase 2 · NCT07473700
- TX000045- Dose APhase 2 · NCT06616974
- TX000045- Dose BPhase 2 · NCT06616974
- Valsartan 40 mgPhase 2 · NCT06053580
- VasopressinPhase 2 · NCT07614438
- VB19055 Dose A QDPhase 2 · NCT07833098
- VB19055 Dose B QDPhase 2 · NCT07833098
- VB19055 Dose C QDPhase 2 · NCT07833098
- VB19055 placebo QDPhase 2 · NCT07833098
- VCT220 Placebo TabletPhase 2 · NCT07360275
- VCT220 TabletPhase 2 · NCT07360275
- Vonoprazan 20 mgPhase 2 · NCT07267260
- AGN-193408 SRPhase 1/2 · NCT04499248
- Ascorbic acid solution (American Regent Laboratories Inc.)Phase 1/2 · NCT04715022
- BEBT-701 InjectionPhase 1/2 · NCT07368608
- BEBT-701 Injection Placebo（0.9% Sodium Chloride Injection）Phase 1/2 · NCT07368608
- Bimatoprost Implant System (High Dose)Phase 1/2 · NCT06120842
- Bimatoprost Implant System (Low Dose)Phase 1/2 · NCT06120842
- CD19-BCMA CAR-T cells infusionPhase 1/2 · NCT06947460
- Combined prescription of the individual medicationsPhase 1/2 · NCT06143566
- Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOLPhase 1/2 · NCT06120842
- CTX340Phase 1/2 · NCT07758634
- Dexmedetomidine Group / Group DPhase 1/2 · NCT06712186
- DIAG723Phase 1/2 · NCT07623525
- Dipyridamole 75 MGPhase 1/2 · NCT07738562
- EUS-portal pressure gradient measurement (PPGM)Phase 1/2 · NCT04633356
- HS235Phase 1/2 · NCT07123779 · NCT07143448
- IMC-003 and PAH background therapyPhase 1/2 · NCT07593027
- IMC-003 placebo and PAH background therapyPhase 1/2 · NCT07593027
- Injector systemPhase 1/2 · NCT07036510
- Kinezodianone R hydrochloridePhase 1/2 · NCT05389267
- Low-level tragus stimulationPhase 1/2 · NCT06802380
- LTPPhase 1/2 · NCT06649110
- Magnesium sulfatePhase 1/2 · NCT04898114
- MoxonidinePhase 1/2 · NCT05312892
- NesiritidePhase 1/2 · NCT02608996
- PolypillPhase 1/2 · NCT06143566
- REGN22530Phase 1/2 · NCT07675824
- SalinePhase 1/2 · NCT04832009 · NCT02646475 · NCT04715022 · NCT06482853
- Semaglutide Pen InjectorPhase 1/2 · NCT05746039
- Sildenafil CitratePhase 1/2 · NCT04898114
- TelaglenastatPhase 1/2 · NCT07223528
- TimoD implantPhase 1/2 · NCT07036510
- TUDCAPhase 1/2 · NCT06025630
- umbilical cord blood CD19-BCMA CAR-T cells infusionPhase 1/2 · NCT06947473
- 0.9% Sodium Chloride InjectionPhase 1 · NCT07191899
- Ablation TreatmentPhase 1 · NCT05369065
- Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, PhentolaminePhase 1 · NCT02966665
- AD-231Phase 1 · NCT07590167
- AD-231A, AD-231D and AD-231CPhase 1 · NCT07590167
- ADX-850Phase 1 · NCT06205628
- Angiotensin IIPhase 1 · NCT01426529
- Angiotensin-(1-7)Phase 1 · NCT02646475 · NCT06482853
- ART101 injectionPhase 1 · NCT07614308
- ArtesunatePhase 1 · NCT06872112
- ATB-1011Phase 1 · NCT07590466
- ATB-1012Phase 1 · NCT07590466
- ATB-U101Phase 1 · NCT07590466
- ATB-U1011Phase 1 · NCT07590466
- ATB-U1012Phase 1 · NCT07590466
- Azilsartan medoxomil 80 mg tabletPhase 1 · NCT06990204
- BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-AscorbatePhase 1 · NCT02966665
- Bifidobacterium probiotics supplementationPhase 1 · NCT07206303
- BIM-DRS High DosePhase 1 · NCT07641296
- BIM-DRS Low DosePhase 1 · NCT07641296
- BQ-123Phase 1 · NCT02966665
- BQ-123, MitoQ, BH4Phase 1 · NCT02966665
- BR1015-1Phase 1 · NCT07421388 · NCT07421375
- BR1015-2Phase 1 · NCT07421414 · NCT07421388 · NCT07421375 · NCT07421401
- BR1015-3Phase 1 · NCT07421414 · NCT07421401
- BR1015-APhase 1 · NCT07421414 · NCT07421388 · NCT07421375 · NCT07421401
- CBP-4888Phase 1 · NCT07282171
- CKD-339Phase 1 · NCT07748702
- D311, D107Phase 1 · NCT07748702
- Edarbi® 80 mg tabletsPhase 1 · NCT06990204
- empagliflozin in treatment pulmonary aerterial hypertensionPhase 1 · NCT06554301
- F230 tabletsPhase 1 · NCT06899815
- Fexofenadine, RanitidinePhase 1 · NCT02966665
- GadoliniumPhase 1 · NCT02648009
- HJB647Phase 1 · NCT07644364
- HS-10522Phase 1 · NCT07609875
- HS-10522 PlaceboPhase 1 · NCT07609875
- Hyperpolarized (13) Pyruvate InjectionPhase 1 · NCT02648009
- IBI3016 Dose 1Phase 1 · NCT07838220
- IBI3016 Dose 2Phase 1 · NCT07838220
- IBI3016 Dose 3Phase 1 · NCT07838220
- IBI3016 Dose 4Phase 1 · NCT07838220
- Investigational Product 1Phase 1 · NCT07682948
- Investigational Product 1 + Investigational Product 2Phase 1 · NCT07682948
- Investigational Product 2Phase 1 · NCT07682948
- KK3910Phase 1 · NCT06823947
- KN060Phase 1 · NCT07191899
- L608 Liposomal inhalation suspensionPhase 1 · NCT06429930
- Labetalol or NifedipinePhase 1 · NCT05989581
- Losartan (COZZAR®)Phase 1 · NCT07784621
- Microcrystalline Cellulose NF (placebo)Phase 1 · NCT07795762
- MN-08 24 mg/dayPhase 1 · NCT05660863
- MN-08 60 mg/dayPhase 1 · NCT05660863
- MTT with antibiotic preconditioning + fiber supplementationPhase 1 · NCT06481852 · NCT07751120
- MTT with antibiotic preconditioning + placebo supplementationPhase 1 · NCT06481852 · NCT07751120
- MTT with placebo + placebo supplementation.Phase 1 · NCT07751120
- MWX401 1Phase 1 · NCT07803835
- MWX401 2Phase 1 · NCT07803835
- MWX401 3Phase 1 · NCT07803835
- MWX401 4Phase 1 · NCT07803835
- MWX401 5Phase 1 · NCT07803835
- Neurotronic Infusion CatheterPhase 1 · NCT05363761
- NitroglycerinPhase 1 · NCT02425566
- PA5436 Ocular Implant, 115mcgPhase 1 · NCT06964061
- Para-aminohippuric AcidPhase 1 · NCT01426529
- Pitavastatin plus EzetemibePhase 1 · NCT07784621
- PNEUMOSTEM®Phase 1 · NCT07368088
- Protek Solo Transseptal CannulaPhase 1 · NCT06770023
- QLS1410Phase 1 · NCT07358858
- QLS1410 (CYP11B2 inhibitor)Phase 1 · NCT07152444
- Reference DrugPhase 1 · NCT07901114
- SAL0140 placeboPhase 1 · NCT07051603
- SC101Phase 1 · NCT07483372
- Sequence A T-R-T-RPhase 1 · NCT07486453
- Sequence B R-T-R-TPhase 1 · NCT07486453
- SHR-4658 Injection.Phase 1 · NCT07230145
- SHR-4658 Placebo InjectionPhase 1 · NCT07230145
- Single Arm non-Randomized Ablation TreatmentPhase 1 · NCT05369065
- SpyGlass IOL with silicone pads (no drug)Phase 1 · NCT07641296
- STX-1150Phase 1 · NCT07428473
- Test DrugPhase 1 · NCT07901114
- Treatment A(AD-231A)Phase 1 · NCT07312773
- Treatment A(AD-2321)Phase 1 · NCT07312799
- Treatment B(AD-231B+AD-231C)Phase 1 · NCT07312773
- Treatment B(AD-2322)Phase 1 · NCT07312799
- Treatment C(AD-231A+AD-231B+AD-231C)Phase 1 · NCT07312773
- Treatment C(AD-2321+AD-2322)Phase 1 · NCT07312799
- TrimethaphanPhase 1 · NCT02726711 · NCT02425566
- VB19055Phase 1 · NCT07254481
- VB19055 placeboPhase 1 · NCT07254481
- XBD173Phase 1 · NCT07697183
- ZMA001 (BC-NKA-20008)Phase 1 · NCT05967299
- (18F)FPGLUEarly phase 1 · NCT05452889
- Ascorbic acidEarly phase 1 · NCT04832009
- CandesartanEarly phase 1 · NCT03583866
- Control group (receiving standard medical therapy alone)Early phase 1 · NCT07662655
- Cosyntropin (Group 3)Early phase 1 · NCT04546126
- Dexamethasone (Group 2)Early phase 1 · NCT04546126
- Dextrose 20 % in 500 ML InjectionEarly phase 1 · NCT04832009
- FNP-59Early phase 1 · NCT04532489
- Hydrochlorothiazide 12.5mgEarly phase 1 · NCT04676399
- Inhaled treprostinilEarly phase 1 · NCT07116681
- IntralipidEarly phase 1 · NCT04832009
- Neuropeptide YEarly phase 1 · NCT04838678
- Percutaneous Pulmonary Artery Denervation (PADN)Early phase 1 · NCT07662655
- PET/CT Scan with FNP-59Early phase 1 · NCT04546126
- Standard Oral Hypoglycemic AgentEarly phase 1 · NCT07209527
- Team-based shared decision-makingEarly phase 1 · NCT07662616
- TrazodoneEarly phase 1 · NCT06281756
- Truway Blood Glucose MonitorEarly phase 1 · NCT07209527
- Truway Portable Ultrasound DeviceEarly phase 1 · NCT07209527
- Use of mouthwashesEarly phase 1 · NCT07356271
Closest to patients
- Riociguat in Children With Pulmonary Arterial Hypertension (PAH)Riociguat in Children With Pulmonary Arterial Hypertension (PAH)Instituto Nacional de Cardiología "Ignacio Chávez" · México D.F., Mexico + 14 more hospitalsPhase 3Primary completion 2020
- Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.Amneal Pharmaceuticals, LLC (sponsor) · 9 hospitals in United StatesPhase 3Primary completion 2022
- TARGET BP I Clinical TrialTARGET BP I Clinical TrialAblative Solutions, Inc. (sponsor) · 5 hospitals in United StatesPhase 3Primary completion 2023
Let us optimize your content
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Randomised trial
Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Effects of Two Rg3-Enriched Korean Ginseng Preparations on Blood Pressure in Adults with Early-Stage Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Nutrients
PubMed · PMID 42943019Publication
Nifedipine-modulated gut microbiota attenuates hypertensive vascular injury through Bifidobacterium-associated inosine-Adora2b signaling.
Nifedipine-modulated gut microbiota attenuates hypertensive vascular injury through Bifidobacterium-associated inosine-Adora2b signaling.
Pharmacological research
PubMed · PMID 42892458Publication
Sex-dependent transcriptional and imaging responses to metformin in young-adult mice with SuHx-induced pulmonary arterial hypertension.
Sex-dependent transcriptional and imaging responses to metformin in young-adult mice with SuHx-induced pulmonary arterial hypertension.
Frontiers in cardiovascular medicine
PubMed · PMID 42920579Publication
Glycated hemoglobin in immediate postpartum, overweight, and pre-gestational arterial hypertension: effect on fasting glycemia one year postpartum.
Glycated hemoglobin in immediate postpartum, overweight, and pre-gestational arterial hypertension: effect on fasting glycemia one year postpartum.
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia
PubMed · PMID 42924389
Find fellow researchers
Groups with active High blood pressure work.
Johns Hopkins University
Baltimore, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Inserm
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it
Capital Medical University
Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Mayo Clinic
Rochester, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Universidade de São Paulo
São Paulo, Brazil
Team details appear once the team leader joins.
Is this your team? Claim it
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Brigham and Women's Hospital
Boston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Imperial College London
London, United Kingdom
Team details appear once the team leader joins.
Is this your team? Claim it
Stanford University
Stanford, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Universitas Airlangga
Surabaya, Indonesia
Team details appear once the team leader joins.
Is this your team? Claim it
Assistance Publique – Hôpitaux de Paris
Paris, France
Team details appear once the team leader joins.
Is this your team? Claim it